Falaschi P, Frajese G, Sciarra F, Rocco A, Conti C
Clin Endocrinol (Oxf). 1978 May;8(5):427-33. doi: 10.1111/j.1365-2265.1978.tb02178.x.
Five clinically normal male volunteers were given metoclopramide, 10 mg t.d.s. for 6 weeks. During treatment prolactin concentrations were elevated (over 50 ng/ml) in all. LH, FSH, testosterone and cortisol concentrations were not altered. No change was observed in LH or FSH responses to LHRH testing 4 weeks after the beginning of therapy, compared with pre-treatment values. A reduction in seminal volume and total sperm count were observed in each subject. Four noticed a decrease in libido and three lost spontaneous erections. While the metoclopramide-induced hyperprolactinaemia could be the cause of the observed changes in semen and erectile activity, it is possible that this dopamine receptor blocking drug might directly affect central or peripheral mechanism of erection, the testes or accessory organs.
五名临床正常的男性志愿者接受了甲氧氯普胺治疗,剂量为每日三次,每次10毫克,持续6周。治疗期间,所有人的催乳素浓度均升高(超过50纳克/毫升)。促黄体生成素(LH)、促卵泡生成素(FSH)、睾酮和皮质醇浓度未发生改变。与治疗前的值相比,治疗开始4周后,对促性腺激素释放激素(LHRH)测试的LH或FSH反应未观察到变化。每个受试者的精液量和总精子数均减少。四人注意到性欲下降,三人失去了自然勃起功能。虽然甲氧氯普胺引起的高催乳素血症可能是观察到的精液和勃起活动变化的原因,但这种多巴胺受体阻断药物也有可能直接影响勃起的中枢或外周机制、睾丸或附属器官。